HighMark Wealth Management’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.16K | Hold |
180
| – | – | ﹤0.01% | 324 |
|
|
2025
Q1 | $8.11K | Hold |
180
| – | – | ﹤0.01% | 315 |
|
|
2024
Q4 | $7.44K | Hold |
180
| – | – | ﹤0.01% | 336 |
|
|
2024
Q3 | $7.02K | Sell |
180
-85
| -32% | -$3.32K | ﹤0.01% | 355 |
|
|
2024
Q2 | $9.06K | Hold |
265
| – | – | 0.01% | 294 |
|
|
2024
Q1 | $6.66K | Hold |
265
| – | – | ﹤0.01% | 343 |
|
|
2023
Q4 | $7.82K | Hold |
265
| – | – | 0.01% | 301 |
|
|
2023
Q3 | $8.37K | Hold |
265
| – | – | 0.01% | 280 |
|
|
2023
Q2 | $6.86K | Hold |
265
| – | – | 0.01% | 313 |
|
|
2023
Q1 | $6.37K | Hold |
265
| – | – | 0.01% | 359 |
|
|
2022
Q4 | $5.17K | Sell |
265
-200
| -43% | -$3.9K | ﹤0.01% | 338 |
|
|
2022
Q3 | $10K | Hold |
465
| – | – | 0.01% | 247 |
|
|
2022
Q2 | $9K | Buy |
+465
| New | +$9K | 0.01% | 264 |
|